-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LGbkLmWqNHr9GpCqdwZ0dWEeFPrYIQbmf9rXYfKBhk4lnqZ45lCoSUI+Tjf5vMtn Wu3PKo4TBIIRC3ji/Qj/BA== 0000919574-10-002182.txt : 20100309 0000919574-10-002182.hdr.sgml : 20100309 20100309120003 ACCESSION NUMBER: 0000919574-10-002182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100305 FILED AS OF DATE: 20100309 DATE AS OF CHANGE: 20100309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE GENETICS INC CENTRAL INDEX KEY: 0001124608 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 1640 MARENGO ST., STREET 2: 6TH FLOOR CITY: LOS ANGELES, STATE: CA ZIP: 90033 BUSINESS PHONE: (323) 224-3900 MAIL ADDRESS: STREET 1: 1640 MARENGO ST., STREET 2: 6TH FLOOR CITY: LOS ANGELES, STATE: CA ZIP: 90033 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANSDOWNE PARTNERS LIMITED PARTNERSHIP CENTRAL INDEX KEY: 0001315309 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33509 FILM NUMBER: 10665989 BUSINESS ADDRESS: STREET 1: 15 DAVIES STREET CITY: LONDON STATE: X0 ZIP: W1K 3AG BUSINESS PHONE: 44-20-7290-5500 MAIL ADDRESS: STREET 1: 15 DAVIES STREET CITY: LONDON STATE: X0 ZIP: W1K 3AG REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANSDOWNE UK STRATEGIC INVESTMENT MASTER FUND LTD CENTRAL INDEX KEY: 0001469444 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33509 FILM NUMBER: 10665990 BUSINESS ADDRESS: STREET 1: C/O FORTIS PRIME FUND SOLUTIONS STREET 2: FORTIS HOUSE, PARK LANE, SPENCER DOCK CITY: DUBLIN STATE: L2 ZIP: 1 BUSINESS PHONE: 353 1 607 1800 MAIL ADDRESS: STREET 1: C/O FORTIS PRIME FUND SOLUTIONS STREET 2: FORTIS HOUSE, PARK LANE, SPENCER DOCK CITY: DUBLIN STATE: L2 ZIP: 1 4 1 p1079251.xml LANSDOWNE/RESPONSE GENETICS X0303 4 2010-03-05 0 0001124608 RESPONSE GENETICS INC RGDX 0001315309 LANSDOWNE PARTNERS LIMITED PARTNERSHIP 15 DAVIES STREET LONDON W1K 3AG X0 UNITED KINGDOM 0 0 1 0 0001469444 LANSDOWNE UK STRATEGIC INVESTMENT MASTER FUND LTD C/O FORTIS PRIME FUND SOLUTIONS FORTIS HOUSE, PARK LANE, SPENCER DOCK DUBLIN I L2 IRELAND 0 0 1 0 Common Stock, par value $0.01 per share 2010-03-05 4 P 0 600769 1.31 A 3658676 D Common Stock, par value $0.01 per share 3658676 I See Footnote These reported securities are held in the account of Lansdowne UK Strategic Investment Master Fund Limited (the "Master Fund"). The Master Fund entered into a purchase agreement with the Issuer as of March 5, 2010 whereby the Master Fund acquired 600,769 shares of common stock from the Issuer in a private transaction (the "Acquisition"). The Master Fund entered into the Acquisition in order to maintain the same percentage of common stock that it beneficially owned prior to the issuance of additional shares of equity securities by the Issuer. Therefore, the percentage of shares beneficially owned by the Master Fund did not change as a result of the Acquisition. These reported securities are held in the account of the Master Fund and may be deemed to be beneficially owned by Lansdowne Partners Limited Partnership by virtue of its role as the investment advisor of the Fund. Lansdowne Partners Limited Partnership disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that Lansdowne Partners Limited Partnership is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Lansdowne Partners Limited Partnership, By: Lansdowne Partners Limited, its general partner, By: /s/ Paul Ruddock, Director 2010-03-09 Lansdowne UK Strategic Investment Master Fund Limited, By: Lansdowne Partners Limited Partnership, its investment advisor, By: Lansdowne Partners Limited, its general partner, By: /s/ Paul Ruddock, Director 2010-03-09 -----END PRIVACY-ENHANCED MESSAGE-----